Robert A Koza Selected Research

Robert A Koza Research Topics

7	Insulin Resistance 01/2022 - 08/2003
5	Obesity 05/2016 - 10/2008
3	Inflammation (Inflammations) 01/2022 - 01/2017
2	Hyperglycemia 01/2022 - 08/2003
2	Hyperinsulinism (Hyperinsulinemia) 01/2022 - 12/2008
2	Body Weight (Weight, Body) 01/2020 - 09/2005
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022
1	Lipidoses 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Weight Gain 01/2022
1	Hypertriglyceridemia 01/2022
1	Weight Loss (Weight Reduction) 01/2020
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018
1	Fibrosis (Cirrhosis) 01/2018
1	Cardiomyopathies (Cardiomyopathy) 01/2018
1	Hypertrophy 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2005
1	Glucose Intolerance 08/2003
1	Fructose Intolerance (Intolerance, Fructose) 09/2002
1	Ketosis 09/2002

6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 08/2003
5	Insulin (Novolin)FDA Link 01/2022 - 08/2003
2	Messenger RNA (mRNA)IBA 01/2018 - 03/2013
2	Uncoupling Protein 1IBA 03/2013 - 10/2008
2	LeptinIBA 03/2013 - 06/2010
2	Glycerol (Glycerine)FDA LinkGeneric 10/2008 - 09/2002
2	Phosphates (Orthophosphate)IBA 10/2008 - 09/2002
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	C-Reactive ProteinIBA 01/2022
1	CollagenIBA 12/2021
1	fibroblast growth factor 21IBA 01/2020
1	AdiponectinIBA 01/2020
1	Methionine (L-Methionine)FDA Link 01/2020
1	AlbuminsIBA 01/2018
1	CreatinineIBA 01/2018
1	Bone Morphogenetic Protein 3IBA 05/2016
1	WD repeat containing planar cell polarity effectorIBA 05/2016
1	Triglycerides (Triacylglycerol)IBA 03/2013
1	Leptin ReceptorsIBA 03/2013
1	LipidsIBA 12/2008
1	A-factor (Streptomyces)IBA 12/2008
1	Glycerolphosphate Dehydrogenase (Glycerol 3 Phosphate Dehydrogenase)IBA 10/2008
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2005
1	Oxidoreductases (Dehydrogenase)IBA 09/2002
1	Nonesterified Fatty Acids (NEFA)IBA 09/2002
1	HyperglycerolemiaIBA 09/2002
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2002

1	Endurance Training 06/2005